Peregrine Announces Positive Top-Line Data From Randomized, Double-Blind Bavituximab Phase II Trial in Second-Line Non-Small Cell Lung Cancer - Yahoo Finance

TUSTIN, CA--(Marketwire -05/21/12)- Peregrine Pharmaceuticals, Inc. (PPHM) today announced positive top-line results from its randomized, double-blind, placebo-controlled Phase IIb trial evaluating two dose levels of bavituximab plus docetaxel ...

supplier Docetaxel works with buy Letrozole - 1UP.COM

Lapatinib was kindly supplied by GlaxoSmith Kline, Business Setting, Health Basic safety. Lapatinib was dissolved in Nilotinib structure, Docetaxel Taxotere, Letrozole clinical trial and saved in the darkish as inventory option at 20 until finally utilization.

Section27, TAC join big pharma bust-up over cancer drug - Mail & Guardian Online

The TAC and Section 27 have joined the fray in a face-off between Aventis Pharma and Cipla Life Sciences in a patent war over cancer drug Docetaxel. The case is of interest to healthcare lobbyists because it could advance patients’ right to access ...

Synta Announces Presentations at the 2012 American Society for Clinical Oncology (ASCO) Annual Meeting - Phramalive.com

“The GALAXY Trial™ (NCT01348126): A Randomized 2b/3 Study of Ganetespib (STA-9090) in Combination with Docetaxel versus Docetaxel Alone in Subjects with Stage IIIB or IV NSCLC.” (Abstract: TPS7613^) – June 2, 1:15 pm - 5:15 pm CT; General Poster ...

Poor-prognosis Estrogen Receptor-positive Disease : Combining Anti-her-2 and Endocrine Therapy - Medscape News

Thus, patients having doce probably got a sub-optimal accumulated dose of anthracyclines. Anthra, anthracycline; cont, containing; DD, dose dense; doce, docetaxel; ER−, estrogen receptor negative; ER+, estrogen receptor positive; FAC, fluorouracil (5-FU ...

Medivation Files Enzalutamide NDA - Analyst Blog - NASDAQ

The companies have evaluated enzalutamide in castration-resistant prostate cancer patients who have received docetaxel therapy. Medivation and Astellas are seeking priority review for their candidate, which if granted, would mean the FDA will ...

Peregrine Announces Positive Top-Line Data From Randomized, Double-Blind Bavituximab Phase II Trial in Second-Line Non-Small - PR Inside

Based on the review of safety and efficacy of this trial conducted by an independent Data Monitoring Committee, no significant safety issues or concerns were identified when comparing the bavituximab containing arms with the docetaxel alone arm.

Lockerbie bomber: new drugs helped Abdelbaset Ali al Megrahi live longer - Daily Telegraph

The following month it was claimed that the assessment that gave Megrahi just three months to live ignored the possibility of him being put on a standard chemotherapy drug, called docetaxel. This can increase life expectancy by 18 months. He was put on ...

Head and neck cancer: Cetuximab in combination with Docetaxel and Cisplatin as induction therapy - Xagena Medical News

Patients treated for locally advanced head and neck cancer may respond better to treatment with the addition of Cetuximab ( Erbitux ) to chemotherapy, according to a phase II study. In the study, 39 patients with stages 3 or 4 head and neck cancer were ...

Adventrx CEO Attempting To Prime His Firm For A Comeback - Seekingalpha.com

a novel emulsion formulation of the chemotherapy drug docetaxel indicated for the treatment of advanced cancer; and ANX-188, a novel, purified, rheologic and antithrombotic compound initially being developed as a first-in-class treatment for pediatric ...